The Insurance Fraud Accountability Act (S. 976) would amend the Affordable Care Act to address fraudulent or unauthorized enrollments in qualified health plans sold through ACA exchanges. The bill focuses on agents, brokers, and related marketing intermediaries, creating new civil and criminal penalties for knowingly or negligently submitting false information in enrollment applications and for other improper conduct tied to exchange enrollments. It also requires the Department of Health and Human Services to establish verification procedures for broker-assisted enrollments in federally operated exchanges, including proof of consumer consent, delayed commission payments until inconsistencies are resolved, consumer notifications about changes to coverage or premium tax credits, and access to account information through consumer-facing tools or a hotline.
The bill further expands federal oversight of the enrollment pipeline by authorizing regulation of field marketing organizations and third-party marketing organizations that participate in the “chain of enrollment.” It directs the Secretary to set state-use criteria for allowing these entities to participate, including a best-interests standard for brokers, licensure and registration requirements, marketing review, and limits on referral compensation unless the participants meet the required standards. The bill also adds transparency measures, including periodic audits based on complaints or suspicious enrollment patterns, referrals of suspected fraud to state insurance departments, and a regularly updated list of suspended or terminated agents and brokers for exchanges, insurers, and states.
If enacted, the bill would amend key provisions of the ACA, especially sections 1311, 1312, and 1411, and would give HHS broader authority to police exchange enrollment practices. It would affect insurance agents and brokers, marketing organizations, exchange administrators, qualified health plans, and consumers enrolling in ACA coverage. The bill is designed to reduce unauthorized plan switches, improper premium tax credit changes, and other forms of enrollment fraud while preserving coverage continuity for consumers.
The general sentiment reflected by the bill’s structure is strongly pro-consumer and anti-fraud, with an emphasis on accountability for brokers and marketers. No vote totals or committee debate are provided, but the bill’s title, findings, and enforcement provisions suggest support for tighter oversight of exchange enrollment practices and concern about deceptive sales tactics. The absence of recorded votes or transcript excerpts means there is no direct evidence of opposition in the provided materials.
The main points of contention likely center on the scope of federal regulation, the compliance burden on brokers and marketing organizations, and the balance between fraud prevention and preserving easy enrollment access. The bill explicitly tries to address that balance by requiring consumer consent and continuity of coverage protections, but the new audit, reporting, licensure, and marketing-review requirements could be viewed as burdensome by industry stakeholders. Potential concerns may also arise over how broadly the Secretary can define marketing materials, chain-of-enrollment participants, and enforcement criteria.
The bill would amend the Affordable Care Act to add new enforcement, verification, and transparency requirements for exchange enrollments, particularly those handled by agents, brokers, field marketing organizations, and third-party marketing organizations. It would authorize civil penalties of up to $50,000 for negligent violations and up to $200,000, plus criminal penalties of up to 10 years’ imprisonment, for knowing and willful fraud by agents or brokers. It would also require HHS to create verification and audit systems, share audit results with state insurance regulators, and maintain lists of suspended or terminated agents and brokers, thereby expanding federal and state oversight of ACA marketplace enrollment practices.
The bill appears to have a generally favorable, consumer-protection-oriented posture, with its core purpose framed as reducing fraud and protecting enrollees from unauthorized or misleading marketplace activity. The available record shows hearings were held, but no votes or transcript excerpts are provided, so there is no documented floor or committee opposition in the supplied materials. Overall, the bill’s design suggests support for stronger enforcement and consumer safeguards rather than a partisan or ideological policy shift.
The likely areas of contention are the breadth of federal authority over ACA enrollment intermediaries, the compliance and reporting obligations imposed on brokers and marketing organizations, and whether the new penalties are proportionate. Industry participants may object to mandatory audits, marketing-material review, registration requirements, and restrictions on referral compensation, while consumer advocates may focus on ensuring the bill does not create barriers to enrollment. Another possible point of debate is the bill’s requirement that coverage not be terminated or changed without consumer consent, which prioritizes continuity of care but may complicate fraud remediation and administrative enforcement.